Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma (original ) (raw ) References
Bae SH, Jung ES, Park YM, Jang JW, Choi JY, Cho SH et al. (2002). Korean J Hepatol 8 : 297–303.
Calvisi DF, Ladu S, Conner EA, Factor VM, Thorgeirsson SS . (2004). Lab Invest 84 : 1137–1147.
Caselmann WH . (1995). J Hepatol 22 (Suppl 1): 34–37.
Cha MY, Kim CM, Park YM, Ryu WS . (2004). Hepatology 39 : 1683–1693.
Christofori G, Semb H . (1999). Trends Biochem Sci 24 : 73–76.
Endo K, Ueda T, Ueyama J, Ohta T, Terada T . (2000). Human Pathol 31 : 558–565.
Feitelson MA, Duan LX . (1997). Am J Pathol 150 : 1141–1157.
Feitelson MA, Reis H, Pan J, Lian Z, Fang J, Liu J et al. (1999) In: Fleig WE (ed). Normal and Malignant Liver Cell Growth: FALK Workshop . Kluwer Academic Publishers: Lancaster, UK. pp 156–170. Google Scholar
Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z . (2002). Oncogene 21 : 2593–2604.
Gottardi CJ, Wong E, Gumbiner BM . (2001). J Cell Biol 153 : 1049–1060.
Henkler F, Koshy R . (1996). J Viral Hepat 3 : 109–121.
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . (1996). Proc Natl Acad Sci USA 93 : 9821–9826.
Inayoshi J, Ichida T, Sugitani S, Tsuboi Y, Genda T, Honma N et al. (2003). J Gastroenterol Hepatol 18 : 673–677.
Jiao W, Miyazaki K, Kitajima Y . (2002). Br J Cancer 86 : 98–101.
Kanai Y, Tsuda H, Sakamoto M, Hirohashi S . (2000). Cancer Lett 148 : 73–80.
Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M et al. (1997). Int J Cancer 71 : 355–359.
Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M et al. (2001). Int J Oncol 18 : 1271–1278.
Lara-Pezzi E, Majano PL, Yanez-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R et al. (2001a). J Hepatol 34 : 409–415.
Lara-Pezzi E, Roche S, Andrisani OM, Sanchez-Madrid F, Lopez-Cabrera M . (2001c). Oncogene 20 : 3323–3331.
Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yanez-Mo M, Carretero M et al. (2001b). Hepatology 33 : 1270–1281.
Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH . (2003). Am J Pathol 163 : 1371–1378.
Lian Z, Liu J, Li L, Li X, Tufan NLS, Clayton MM et al. (2003). Neoplasia 5 : 229–244.
Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P et al. (1999). Oncogene 18 : 1677–1687.
Liu J, Feitelson MA . (2004). Methods Mol Med 95 : 71–84.
Masuda T, Saito H, Kaneko F, Atsukawa K, Morita M, Inagaki H et al. (2000). In vitro Cell Dev Biol 36 : 387–394.
Matsumura T, Makino R, Mitamura K . (2001). Clin Cancer Res 7 : 594–599.
Nelson WJ, Nusse R . (2004). Science 303 : 1483–1487.
Orsulic S, Huber O, Aberle H, Arnold S, Kemler R . (1999). J Cell Sci 112 : 1237–1245.
Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K et al. (2003). J Pathol 201 : 250–259.
Slagle BL, Zhou YZ, Birchmeier W, Scorsone KA . (1993). Hepatology 18 : 757–762.
Su Q, Liu JF, Zhang SX, Li DF, Yang JJ . (1994). Hepatology 19 : 788–799.
Sun BS, Zhu X, Clayton MM, Pan J, Feitelson MA . (1998). Hepatology 27 : 228–239.
Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P et al. 1997. Oncogene 14 : 395–404.
Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA . (1995). J Virol 69 : 1851–1859.
Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, Bosch DA et al. (2002). Glia 38 : 329–338.
Wang W, London WT, Lega L, Feitelson MA . (1991). Hepatology 14 : 29–37.
Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC . (1994). Proc Natl Acad Sci USA 91 : 2230–2234.
Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA . (2002). Hepatology 36 : 692–701.
Wong AST, Gumbiner BM . (2003). J Cell Biol 161 : 1191–1203.
Wong CM, Fan ST, Ng IO . (2001). Cancer 92 : 136–145.
Wu JC, Merlino G, Fausto N . (1994). Proc Natl Acad Sci USA 91 : 674–678.
Yang B, Guo M, Herman JG, Clark DP . (2003). Am J Pathol 163 : 1101–1107.
Yano T, Hernandez-Blazquez FJ, Omori Y, Yamasaki H . (2001). Carcinogenesis 22 : 1593–1600.
Download references